Researchers performed a randomized controlled trial (RCT) to evaluate the safety and effectiveness of cola in relieving esophageal meal bolus impaction.
The trial will enrol patients with ER+/HER2-negative metastatic breast cancer. Credit: Maria Sbytova via Shutterstock. Olema Oncology has announced another clinical trial collaboration and supply
Zachary Schultz, CSMC, CRCR, Sr. Director of Product Policy and Solutions at EnableComp Healthcare providers navigating Veterans Administration (VA) claims face complex eligibility requirements, multiple